MYCN-amplified RB1-proficient (MYCNARB1+/+) retinoblastomas are diagnosed at an earlier age compared with classic RB1–/– retinoblastomas and display more aggressive clinical behavior.6 This evidence concerns the gene MYCN and retinoblastoma.